TNFSF9 Protein (AA 50-254) (His-DYKDDDDK-Strep II Tag)
-
- Target See all TNFSF9 Proteins
- TNFSF9 (Tumor Necrosis Factor (Ligand) Superfamily, Member 9 (TNFSF9))
- Protein Type
- Recombinant
- Protein Characteristics
- AA 50-254
-
Origin
- Human
-
Source
- HEK-293T Cells
- Purification tag / Conjugate
- This TNFSF9 protein is labelled with His-DYKDDDDK-Strep II Tag.
- Application
- SDS-PAGE (SDS), Western Blotting (WB), ELISA, Protein Interaction (PI)
- Purpose
- TNFSF9 (Human) Recombinant Protein
- Sequence
- ACPWAVSGAR ASPGSAASPR LREGPELSPD DPAGLLDLRQ GMFAQLVAQN VLLIDGPLSW YSDPGLAGVS LTGGLSYKED TKELVVAKAG VYYVFFQLEL RRVVAGEGSG SVSLALHLQP LRSAAGAAAL ALTVDLPPAS SEARNSAFGF QGRLLHLSAG QRLGVHLHTE ARARHAWQLT QGATVLGLFR VTPEIPAGLP SPRSE
- Characteristics
- Purified TNFSF9 (AAI04806.1 50 a.a. - 254 a.a.) human recombinant protein with His-Flag-StrepII tag at N-terminus expressed in human cells.
- Purification
- Transfection of pSuper-TNFSF9 plasmid into HEK293T cell, and the expressed protein was purified by Strep-Tactin affinity column.
- Top Product
- Discover our top product TNFSF9 Protein
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 10 μg/mL
- Buffer
- 100 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, and 5 mM desthiobiotin.
- Preservative
- Other preservative
- Handling Advice
- Aliquot to avoid repeated freezing and thawing.
- Storage
- -80 °C
-
- Target
- TNFSF9 (Tumor Necrosis Factor (Ligand) Superfamily, Member 9 (TNFSF9))
- Alternative Name
- TNFSF9 (TNFSF9 Products)
- Synonyms
- TNFSF9 Protein, 4-1BB-L Protein, 4-1BBL Protein, AI848817 Protein, Cd137l Protein, Ly63l Protein, CD137L Protein, TNF superfamily member 9 Protein, tumor necrosis factor (ligand) superfamily, member 9 Protein, Tnfsf9 Protein, LOC476729 Protein, TNFSF9 Protein
- Background
-
Gene: tumor necrosis factor (ligand) superfamily, member 9
Synonyms: 4-1BB-L, CD137L - Gene ID
- 8744
- Pathways
- Activated T Cell Proliferation, Cancer Immune Checkpoints
-